We serve pharmaceutical, chemical, research, academic, laboratory, manufacturing, and industrial customers with reliable nationwide delivery.
They are personalized protocols backed by proven science, designed for people who are ready to stop guessing and start seeing real, lasting change
2 Connect with a provider After evaluating your consultation, a provider licensed in your state will prescribe treatment (if clinically appropriate)
NMPA Approves Oral Small-Molecule Inhibitor On October 22, Boehringer Ingelheim announced that its oral PDE4B inhibitor, Nerandomilast, has been approved by the NMPA through the priority review pathway for the treatment of adult idiopathic pulmonary fibrosis (IPF)
Her new insurance company pays for a medicine with the same active ingredient if it is used to treat diabetes, and Khoury is insulin-resistant, which can be a prelude to type 2 diabetes